Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Acquisitions (2018)

Historic Acquisitions for Harvard Bioscience (HBIO) over the last 7 years, with Q4 2018 value amounting to $540000.0.

  • Harvard Bioscience's Acquisitions changed N/A to $540000.0 in Q4 2018 from the same period last year, while for Sep 2019 it was $540000.0, marking a year-over-year decrease of 9920.6%. This contributed to the annual value of $68.5 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Harvard Bioscience's Acquisitions is $540000.0.
  • Harvard Bioscience's Acquisitions' 5-year high stood at $67.4 million during Q1 2018, with a 5-year trough of $540000.0 in Q4 2018.
  • For the 3-year period, Harvard Bioscience's Acquisitions averaged around $17.1 million, with its median value being $4.5 million (2015).